Precipio (NASDAQ:PRPO) Stock Price Crosses Below 200-Day Moving Average of $6.62

Precipio, Inc. (NASDAQ:PRPO) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.62 and traded as low as $6.61. Precipio shares last traded at $6.74, with a volume of 1,653 shares traded.

Precipio Stock Performance

The company has a current ratio of 1.17, a quick ratio of 1.05 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average price of $6.40 and a 200-day moving average price of $6.62. The firm has a market capitalization of $9.63 million, a price-to-earnings ratio of -1.48 and a beta of 1.61.

Hedge Funds Weigh In On Precipio

An institutional investor recently bought a new position in Precipio stock. Virtu Financial LLC acquired a new stake in Precipio, Inc. (NASDAQ:PRPO) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 45,146 shares of the biotechnology company’s stock, valued at approximately $25,000. Virtu Financial LLC owned about 0.20% of Precipio as of its most recent filing with the SEC. Hedge funds and other institutional investors own 10.45% of the company’s stock.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests.